AgraFlora Organics International Inc.
(“
AgraFlora” or the
“
Company”) (
CSE: AGRA) (Frankfurt:
PU31) (OTCPK: PUFXF), a growth oriented and diversified
international cannabis company, is pleased to provide the following
licensing guidance and operational updates pertaining to its
cannabinoid-infused beverage bottling facility (the “Facility”)
situated in the Greater Toronto Area:
- Successful submission of all required application documents to
Health Canada for a five-year Research License under the Cannabis
Act; ○ End of Q3 2019 anticipated award of Research
License with research, development and testing activities to
commence immediately thereafter; ○ Engagement of 3 Sixty Risk
Solutions Ltd. for application acceleration and development of
standard operating procedure (SOPs), thus solidifying AgraFlora’s
pole position as a first mover in the Canadian cannabinoid-infused
beverage marketplace;
- Build out of a on-site, dedicated cannabinoid research
laboratory at its GMP-certified Facility; ○ Installation of
state-of-the-art equipment for the weighing, handling and
processing micro dosages of CBD and THC compounds, including
magnetic mixers, homogenizers and high pressure liquid
chromatograph (“HPLC”);
- On-going bottling line retrofit initiatives to deliver products
ranging from functional (CBD-infused) water and juice based
beverages to THC-infused coffees and teas in a number of formats
including, glass bottles, polyethylene terephthalate (“PET”)
bottles and aluminum cans; ○ Annualized throughput of up to
30 million bottles; ○ Customized to incorporate Agraflora's
patented pharmaceutical-grade dispensing cap technology and
hermetically-sealed bottle cap cannabinoid delivery mechanisms
designed to preserve the static state of CBD/THC extracts
(https://agraflora.com/brands/health-cap-holdings/); -
Developed over five-years, with research and development
expenditures of over $30 million; - Robust patent portfolio,
including seven design patents, ten utility patents, as well as
certified as a pharma grade medical device under three US Medical
Patents;
- Exclusive care and control of a portfolio of established
cannabinoid-infused product formulation recipes already featured in
mature US marketplaces; ○ Refined by a consortium of food
engineers, nutritionists and scientists to optimize
bioavailability, consistent dosing protocols and flavouring
AgraFlora’s cannabinoid-infused bottling Facility boasts
extensive manufacturing experience for leading beverage brands,
such as Heineken and SABMiller, as well as the Coca-Cola Company.
The Facility is strategically situated in the Greater Toronto Area
(the “GTA”) affording the company unbridled access to the largest
addressable Canadian marketplace. The GTA is buoyed by established
infrastructure, offering the flexibility to accommodate shipments
from multiple ports and hubs across North America.
With annualized throughput of up to 30 million bottles the
Facility is equipped with state-of-the-art bottling equipment,
configured to conduct rapid production runs, with minimal downtime
for production line changeovers. Fully operational, the Facility
has been granted the following industry certifications:
- Good manufacturing practices (“GMP”);
- Canadian organic standards;
- Certified vegan;
- Fair trade certification (“ISO 17065”); and,
- Kosher facility status.
The Facility has submitted its application to Health Canada
under the Cannabis Act for a five year Research License. Licensing
is anticipated for the end of Q3 2019, with proposed research,
development and testing activities to commence immediately
thereafter. Upon successful award of the Research License, the
Facility plans to immediately commence cannabinoid related research
and development activities, including:
- Establishment of extraction protocols to isolate specific
desirable compounds, including cannabidiol (“CBD”),
tetrahydrocannabinol (“THC”) and tetrahydrocannabivarin
(“THCV”)
- Cannabinoid extract infusion analysis relating to formulation
and pilot batching;
- Identification of process and physiochemical product attributes
and pair with analytically guided optimization;
- Development of optimized blend formulations for water
solubility and shelf stability ratios/forms;
- High pressure homogenization to produce superfine emulsions
from cannabis oil; and,
- Centrifugal partition chromatography to develop compounds in a
powdered format.
In anticipation of its anticipated Health Canada issued Research
License, the Facility has commenced retrofit initiatives including
the build out of a cannabis research laboratory within its current
GMP-certified premises. The secure laboratory will consist of
state-of-the-art equipment for weighing, handling and processing
micro dosages of CBD and THC compounds, including magnetic mixers,
homogenizers and high pressure liquid chromatograph.
Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora
stated: “The functional beverage category is increasingly becoming
the popular choice among consumers who are seeking low-calorie,
nutrient-dense options as a healthy alternative to traditional
beverages. The global functional beverage market is expected to
grow at a compound annual growth rate of 6.1 per cent to
US$93.68-billion by 2019, according to a new study by Grand View
Research Inc.1.
Augmented by innovative industry technologies, including
pharmaceutical-grade mixing tanks, advanced UV sterilization
techniques and custom extended-shelf-life bottling lines,
AgraFlora’s functional beverage portfolio and bottling facility
will address major and growing consumer health and wellness needs
for the modern lifestyle. Our industry leading bottling facility,
coupled with exclusive access to a suite of established
cannabinoid-infused product formulation recipes already proven to
garner considerable attention in mature US marketplaces such as
Colorado further reinforces our position as a leader in the next
phase of Canadian cannabis normalization.
The marketing and eventual distribution of our beverage products
will follow additional testing, and will be subject to necessary
approvals and licences to be granted by Health Canada and
regulatory authorities in other territories."
AgraFlora’s cannabis-infused beverages will leverage patented
pharmaceutical-grade dispensing cap technology, as well as advanced
delivery mechanisms to provide optimized ingredient effectiveness
for the end consumers. With a simple twist of the cap, this
intuitive technology enables the blending of premium, preserved
cannabinoids into an assortment of bottled liquids, ensuring the
consumer receives the full range of functional benefits at the
moment of consumption.
The delivery mechanism boasts a patented airtight and
moisture-resistant bottle cap to protect volatile ingredients such
as cannabinoids, antibiotics, probiotics, vitamins and minerals
resulting in superior shelf stability for infused bottled
beverages. The dispensing cap technology allows for increased
efficacy when compared with premixed beverages, which are
susceptible to rapid nutrient deterioration.
Refined over five years, with research and development
expenditures of $30 million, AgraFlora plans to deploy its
exclusive rights to a marquee dispensing cap technology and
delivery mechanism to revolutionize the North American
cannabinoid-infused beverage marketplace.
The Company is also pleased to announce to appointment of Mr.
Peter Nguyen as Chief Financial Officer. Mr. Nguyen is a Chartered
Professional Accountant and holds a degree from the University of
British Columbia. He is an officer and director of several
reporting companies listed on the TSX Venture Exchange and the CSE
with both domestic and international operations. Mr. Nguyen has
held senior financial positions for both public and private
companies where he provided assurance, corporate finance, tax and
business advisory services
AgraFlora also announces the resignation of Mr. Chris Cherry as
Chief Financial Officer. The Company would like to sincerely thank
Mr. Cherry for his many years of services to date, and wishes him
the best of luck with his future endeavours.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and
diversified company focused on the international cannabis industry.
It owns an indoor cultivation operation in London, ON and is a
joint venture partner in Propagation Service Canada and its
large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The
Company has a successful record of creating shareholder value and
is actively pursuing other opportunities within the cannabis
industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy Chairman & CEOT: (604) 682-2928
For additional information: |
|
|
|
AgraFlora Organics
International Inc. Tim McNultyE: ir@agraflora.com T: (800)
783-6056 |
For French inquiries: Remy
Scalabrini, Maricom Inc.E: rs@maricom.ca T: (888)
585-MARI |
The CSE and Information Service Provider have
not reviewed and does not accept responsibility for the accuracy or
adequacy of this release.
Forward-looking Information Cautionary
Statement
Except for statements of historic fact, this
news release contains certain "forward-looking information" within
the meaning of applicable securities law. Forward-looking
information is frequently characterized by words such as "plan",
"expect", "project", "intend", "believe", "anticipate", "estimate"
and other similar words, or statements that certain events or
conditions "may" or "will" occur. Forward-looking statements are
based on the opinions and estimates at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those anticipated in the forward-looking statements
including, but not limited to delays or uncertainties with
regulatory approvals, including that of the CSE. There are
uncertainties inherent in forward-looking information, including
factors beyond the Company’s control. There are no assurances that
the business plans for AgraFlora Organics described in this news
release will come into effect on the terms or time frame described
herein. The Company undertakes no obligation to update
forward-looking information if circumstances or management's
estimates or opinions should change except as required by law. The
reader is cautioned not to place undue reliance on forward-looking
statements. Additional information identifying risks and
uncertainties that could affect financial results is contained in
the Company’s filings with Canadian securities regulators, which
are available at www.sedar.com.
1
https://www.grandviewresearch.com/press-release/global-functional-drinks-market
Agra Ventures (CSE:AGRA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agra Ventures (CSE:AGRA)
Historical Stock Chart
From Jul 2023 to Jul 2024